Market Research Logo

GenePOC Inc - Product Pipeline Analysis, 2018 Update

Summary

GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group, is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving optimal patient management. It offers diagnostic instruments based on a novel centripetal technology platform. GenePOC also provides automated point-of-care molecular diagnostic system that facilitates early detection and the prevention of infectious diseases. The company’s POC diagnostic system is employed in the detection of respiratory tract infections, neonatal infections, gastrointestinal tract, and others. GenePOC is headquartered in Quebec City, Quebec, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company GenePOC Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


  • GenePOC Inc Company Overview
    • GenePOC Inc Company Snapshot
    • GenePOC Inc Pipeline Products and Ongoing Clinical Trials Overview
      • Table GenePOC Inc Pipeline Products and Ongoing Clinical Trials Overview
      • Table GenePOC Inc Pipeline Products by Equipment Type
      • Table Figure 1: GenePOC Inc Pipeline Products by Equipment Type
      • Table GenePOC Inc Pipeline Products by Indication
  • GenePOC Inc – Pipeline Analysis Overview
    • GenePOC Inc - Key Facts
      • Table GenePOC Inc, Key Facts
    • GenePOC Inc - Major Products and Services
      • Table GenePOC Inc, Major Products and Services
    • GenePOC Inc Pipeline Products by Development Stage
      • Table Figure 2: GenePOC Inc Pipeline Products by Development Stage
      • Table GenePOC Inc Number of Pipeline Products by Development Stage
      • Table GenePOC Inc Pipeline Products Summary by Development Stage
    • GenePOC Inc Ongoing Clinical Trials by Trial Status
      • Table Figure 3: GenePOC Inc Ongoing Clinical Trials by Trial Status
      • Table GenePOC Inc Ongoing Clinical Trials by Trial Status
      • Table GenePOC Inc Ongoing Clinical Trials Summary
  • GenePOC Inc Pipeline Products Overview
    • GenePOC GBS DS Assay
      • GenePOC GBS DS Assay Product Overview
        • Table GenePOC GBS DS Assay - Product Status
        • Table GenePOC GBS DS Assay - Product Description
      • GenePOC GBS DS Assay Clinical Trial
        • Table GenePOC GBS DS Assay - Prospective Study for Clinical Validation of the Molecular-based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes of Gram-negative Bacteria (blaIMP, blaKPC, blaNDM, blaOXA-48-like and blaVIM) in Rectal Swab Samples From Patients Suspected of Being Colonized. The Targeted Organisms are Enterobacteriaceae, Acinetobacter Baumannii, and Pseudomonas Aeruginosa
    • revogene - Bacillus atrophaeus subsp. globigii Assay
      • revogene - Bacillus atrophaeus subsp. globigii Assay Product Overview
        • Table revogene - Bacillus atrophaeus subsp. globigii Assay - Product Status
        • Table revogene - Bacillus atrophaeus subsp. globigii Assay - Product Description
    • revogene - Bacillus subtilis Assay
      • revogene - Bacillus subtilis Assay Product Overview
        • Table revogene - Bacillus subtilis Assay - Product Status
        • Table revogene - Bacillus subtilis Assay - Product Description
    • revogene - Campylobacter jejuni Assay
      • revogene - Campylobacter jejuni Assay Product Overview
        • Table revogene - Campylobacter jejuni Assay - Product Status
        • Table revogene - Campylobacter jejuni Assay - Product Description
    • revogene - Candida albicans Assay
      • revogene - Candida albicans Assay Product Overview
        • Table revogene - Candida albicans Assay - Product Status
        • Table revogene - Candida albicans Assay - Product Description
    • revogene - Clostridium difficile Assay
      • revogene - Clostridium difficile Assay Product Overview
        • Table revogene - Clostridium difficile Assay - Product Status
        • Table revogene - Clostridium difficile Assay - Product Description
    • revogene - Enterococcus faecalis Assay
      • revogene - Enterococcus faecalis Assay Product Overview
        • Table revogene - Enterococcus faecalis Assay - Product Status
        • Table revogene - Enterococcus faecalis Assay - Product Description
    • revogene - Escherichia coli Assay
      • revogene - Escherichia coli Assay Product Overview
        • Table revogene - Escherichia coli Assay - Product Status
        • Table revogene - Escherichia coli Assay - Product Description
    • revogene - Influenza A Assay
      • revogene - Influenza A Assay Product Overview
        • Table revogene - Influenza A Assay - Product Status
        • Table revogene - Influenza A Assay - Product Description
    • revogene - Respiratory Tract Infections Assay
      • revogene - Respiratory Tract Infections Assay Product Overview
        • Table revogene - Respiratory Tract Infections Assay - Product Status
        • Table revogene - Respiratory Tract Infections Assay - Product Description
    • revogene - Salmonella enterica Assay
      • revogene - Salmonella enterica Assay Product Overview
        • Table revogene - Salmonella enterica Assay - Product Status
        • Table revogene - Salmonella enterica Assay - Product Description
    • revogene - Sexually Transmitted Infections Assay
      • revogene - Sexually Transmitted Infections Assay Product Overview
        • Table revogene - Sexually Transmitted Infections Assay - Product Status
        • Table revogene - Sexually Transmitted Infections Assay - Product Description
    • revogene - Staphylococcus Assay
      • revogene - Staphylococcus Assay Product Overview
        • Table revogene - Staphylococcus Assay - Product Status
        • Table revogene - Staphylococcus Assay - Product Description
    • Triplex Molecular Diagnostic Assay
      • Triplex Molecular Diagnostic Assay Product Overview
        • Table Triplex Molecular Diagnostic Assay - Product Status
        • Table Triplex Molecular Diagnostic Assay - Product Description
  • GenePOC Inc - Key Competitors
  • GenePOC Inc - Key Employees
    • Table GenePOC Inc, Key Employees
  • GenePOC Inc - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
      • Table GenePOC Inc, Other Locations
  • Recent Developments
    • GenePOC Inc, Recent Developments
      • Mar 22, 2018: Novacyt Signs Assay Development Contract for Diagnosis of Respiratory Infections with GenePOC
      • Feb 19, 2018: GenePOC Launches Its revogene Instrument and GBS LB Test in Canada
      • Nov 28, 2017: GenePOC Launches Its GenePOC CDiff Test In The United States
      • Oct 12, 2017: GenePOC Launches its new GenePOC GBS DS Test
      • Sep 27, 2017: Genepoc to Attend EMMD in Noortwijk, the Netherlands, From October 11th to 13th
      • Jun 01, 2017: GenePOC announces FDA clearance for GBS LB test
      • Feb 02, 2017: GenePOC Announces GenePOC GBS Assay Launch in Europe and Middle East
      • Feb 02, 2017: GenePOC announces launch of CE-IVD marked test GenePOC CDiff in Europe and Middle East
      • Jan 11, 2017: GenePOC Announces CE Marking for its Revogene Instrument
      • Jan 11, 2017: GenePOC Announces CE Marking for its Second Bacteriological Test, GenePOC CDiff
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report